-
Development of a New, Adaptable Patient-Reported Outcome Measure of Treatment Satisfaction
Sep 9, 2025, 16:22 PM -
Traditional vs. Generative AI: A Rapid Systematic Review Assessing Accuracy and Efficiency of AI in Title/Abstract Screening
Sep 9, 2025, 16:22 PM -
Hereditary Transthyretin Amyloidosis (ATTRv) Below the Age of 70 Healthcare Resource Utilization and Mortality
Sep 9, 2025, 16:22 PM -
Development and Implementation of a Health and Well-being Index to Inform Risk Management and Patient Engagement in a Colombian Health Insurance Plan
Sep 9, 2025, 16:22 PM -
Estimating the Age- and Sex-Standardized Prevalence and Incidence of Depression and Anxiety in UK Adults Using the THIN Database
Sep 9, 2025, 16:22 PM -
Obesity and MASH in the UK
Sep 9, 2025, 16:22 PM -
An Irish Retrospective Analysis of Oncology Reimbursement Applications Considered by HSE Drugs Group 2022-2024
Sep 9, 2025, 16:22 PM -
Opportunity Gain in Resources as New Framework to Counterpart Burnout in Healthcare Systems
Sep 9, 2025, 16:22 PM -
Institutional Profiles and the Likelihood of Unfavorable Submissions in Public Consultations on Breast Cancer Drugs in Brazil’s Supplementary Health System
Sep 9, 2025, 16:22 PM -
Incidence of Intracerebral Hemorrhage in Patients With Mild Cognitive Impairment or Alzheimer’s Dementia Among United States Medicare Beneficiaries
Sep 9, 2025, 16:22 PM -
A Comparison of the Potential Public Health Impact of PCV15 and PCV20 in French Infants
Sep 9, 2025, 16:22 PM -
Epidemiology of Breast Cancer in France
Sep 9, 2025, 16:22 PM -
The Czech Republic’s Dedicated Orphan Drug Reimbursement Mechanism 2022-2025: Improvements in Access
Sep 9, 2025, 16:22 PM -
Burden of Illness and Healthcare Resource Utilization Among Patients Newly Diagnosed With Amyotrophic Lateral Sclerosis in the United States: A Retrospective, Observational, Cohort Design Study
Sep 9, 2025, 16:22 PM -
Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)
Sep 9, 2025, 16:22 PM -
Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Network Meta-Analysis Comparing Treatments to Paclitaxel
Sep 9, 2025, 16:22 PM -
Drifting in the Network: Catching Baseline Shifts Before They Wreck Your Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Drivers and Barriers of Biosimilar Uptake in APAC
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Ukraine and in Kiev City, Lviv, and Cherkasy Regions
Sep 9, 2025, 16:22 PM -
Mapping Disease-Specific Patient-Reported Outcome Measures (PROMs) to EQ-5D Utility Scores: A Systematic Review
Sep 9, 2025, 16:22 PM
